查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1968709

数位生物製造市场分析及预测（至2035年）：按类型、产品类型、服务、技术、组件、应用、流程、部署类型、最终用户和解决方案划分

Digital Biomanufacturing Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Process, Deployment, End User, Solutions
出版日期: | 出版商: Global Insight Services | 英文 353 Pages | 商品交期: 3-5个工作天内

价格
简介目录

数位生物製造市场预计将从2024年的28亿美元成长到2034年的151亿美元，复合年增长率约为18.4%。数位生物製造市场涵盖将数位技术整合到生物生产过程中，以提高效率、精确度和扩充性。该市场利用数据分析、机器学习和物联网来优化生物製程、降低成本并提高产品品质。对个人化医疗和永续生产日益增长的需求正在推动自动化、即时监控和预测建模方面的创新，从而促进市场成长。

受生物技术和自动化进步的推动，数位化生物製造市场正经历强劲成长。在产品细分市场中，生物加工设备表现最为突出，它们对于优化生产效率和产品品质至关重要。生物反应器和发酵槽在推动可扩展生物製造製程创新方面发挥关键作用。软体细分市场（包括数据分析和製程控制解决方案）是成长第二快的细分市场，这反映了对生物製造操作进行精确监控和优化的需求。在应用细分市场中，药物研发和生产占据主导地位，这主要得益于对生物製药和个人化医疗日益增长的需求。细胞和基因治疗製造是成长第二快的细分市场，其成长动力来自再生医学和标靶治疗的进步。这些领域中数位技术的整合提高了流程透明度，缩短了产品上市时间，并提高了对严格监管标准的合规性。对数位双胞胎和人工智慧驱动的生物加工的投资正在进一步加速市场成长，为相关人员提供了盈利的机会。

市场区隔
类型 连续生物製造、间歇生物製造、混合生物製造
产品 生物反应器、一次性系统、层析法系统、过滤系统、离心机、混合系统、细胞培养基、缓衝液和试剂
服务 流程开发、咨询、训练、维护与支援、品质保证、法规遵循、数据分析
科技 机器学习、人工智慧、物联网、区块链、数位双胞胎、3D生物列印、云端运算、巨量资料分析
成分 软体、硬体和生物组件
应用领域 药品、生物製药、基因疗法、细胞疗法、疫苗生产、酵素生产、生质燃料
过程 上游工程、下游製程、配方、包装
实施表格 本机部署、云端部署、混合式部署
最终用户 生技公司、製药公司、研究机构、学术机构、契约製造组织
解决方案 整合式、独立式和客製化解决方案

市场概况：

受竞争性定价策略和创新产品推出的影响，数位生物製造市场正经历着市场份额的动态变化。各公司正透过利用先进的生物技术和推出前沿解决方案来巩固其市场地位。该市场的特点是产品多样化，各公司既注重成本效益，也注重技术优势。策略伙伴关係和联盟进一步塑造了这种竞争格局，它们在推动创新和拓展产品系列发挥关键作用。对数位生物製造市场的竞争基准分析表明，主要行业参与者占据主导地位，并积极塑造市场趋势。监管影响，特别是北美和欧洲严格的合规要求，对制定市场标准至关重要。亚太地区正崛起为投资热点，这得益于有利的法规结构和政府主导的措施。随着市场的不断发展，数位技术和自动化的整合有望推动成长，并在监管挑战中为相关人员提供丰厚的成长机会。

主要趋势和驱动因素：

受自动化和人工智慧技术进步的推动，数位生物製造市场正经历强劲成长。这些技术正在革新生产流程，提高效率并降低成本。物联网设备的整合也是关键趋势，它实现了对生物过程的即时监控。这种连接性有助于数据驱动的决策，进而优化生产结果。此外，对个人化医疗日益增长的需求也在推动市场发展，因为数位生物製造能够实现大规模客製化生产。监管机构也越来越支持这一领域，他们认识到数位生物製造在药物研发方面具有创新和提高效率的潜力。永续性也是一个关键驱动因素，数位化解决方案能够减少生物製造过程中的废弃物和能源消耗。人们对合成生物学的兴趣日益浓厚，这正在拓展数位生物製造的潜在应用。企业正在加大研发投入，以充分利用这些技术，从而为新产品开发创造机会。随着产业的不断发展，伙伴关係关係不断涌现，推动了创新和市场扩张。

限制与挑战：

数位生物製造市场面临许多显着的限制和挑战。其中一个主要挑战是尖端数位技术所需的高额初始投资，这阻碍了中小企业进入市场。此外，将数位系统与现有生物製造流程整合通常需要专业知识，这构成了一道重要的技术壁垒。资料安全和隐私问题也是一大障碍，因为整合数位系统会增加网路威胁和资料外洩的风险。合规性同样是一项重大挑战，因为遵守复杂的国际监管环境既耗时又昂贵。此外，能够操作和维护先进数位生物製造系统的熟练人员短缺。这种技能缺口会导致效率低下，并阻碍新技术的有效应用。所有这些因素共同构成了数位生物製造领域市场成长和创新的重大障碍。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 连续生物製造
    • 批次式生物製造
    • 混合生物製造
  • 市场规模及预测：依产品划分
    • 生物反应器
    • 免洗系统
    • 层析法系统
    • 过滤系统
    • 离心机
    • 混合系统
    • 细胞培养基
    • 缓衝液和试剂
  • 市场规模及预测：依服务划分
    • 製程开发
    • 咨询
    • 训练
    • 维护和支援
    • 品质保证
    • 监理合规
    • 数据分析
  • 市场规模及预测：依技术划分
    • 机器学习
    • 人工智慧
    • 物联网 (IoT)
    • 区块链
    • 数位双胞胎
    • 3D生物列印
    • 云端运算
    • 巨量资料分析
  • 市场规模及预测：依组件划分
    • 软体
    • 硬体
    • 生物成分
  • 市场规模及预测：依应用领域划分
    • 製药
    • 生物製药
    • 基因治疗
    • 细胞疗法
    • 疫苗生产
    • 酵素的生产
    • 生质燃料
  • 市场规模及预测：依製程划分
    • 上游工程
    • 下游工艺
    • 配方
    • 包装
  • 市场规模及预测：依发展状况
    • 本地部署
    • 基于云端的
    • 杂交种
  • 市场规模及预测：依最终用户划分
    • 生技公司
    • 製药公司
    • 研究机构
    • 学术机构
    • 契约製造组织（CMO）
  • 市场规模及预测：按解决方案划分
    • 整合解决方案
    • 独立解决方案
    • 客製化解决方案

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章 公司简介

  • Ginkgo Bioworks
  • Zymergen
  • Arzeda
  • Amyris
  • Conagen
  • Genomatica
  • Pivot Bio
  • Synthace
  • Benchling
  • Inscripta
  • Twist Bioscience
  • Cambrium
  • Evonetix
  • Cellibre
  • Molecular Assemblies

第九章：关于我们

简介目录
Product Code: GIS33788

Digital Biomanufacturing Market is anticipated to expand from $2.8 billion in 2024 to $15.1 billion by 2034, growing at a CAGR of approximately 18.4%. The Digital Biomanufacturing Market encompasses the integration of digital technologies in bioproduction processes, enhancing efficiency, precision, and scalability. This market leverages data analytics, machine learning, and IoT to optimize bioprocesses, reduce costs, and improve product quality. The rising demand for personalized medicine and sustainable production fuels innovation in automation, real-time monitoring, and predictive modeling, driving market growth.

The Digital Biomanufacturing Market is experiencing robust growth, fueled by advancements in biotechnology and automation. Within the product segment, bioprocessing equipment emerges as the top performer, essential for optimizing production efficiency and product quality. Bioreactors and fermenters are pivotal, driving innovation in scalable biomanufacturing processes. The software segment, encompassing data analytics and process control solutions, is the second highest-performing, reflecting the need for precise monitoring and optimization of biomanufacturing operations. In the application segment, drug development and production lead, driven by the increasing demand for biologics and personalized medicine. The second highest-performing sub-segment is cell and gene therapy manufacturing, propelled by breakthroughs in regenerative medicine and targeted therapies. The integration of digital technologies in these areas enhances process transparency, reduces time-to-market, and improves compliance with stringent regulatory standards. Investments in digital twins and AI-driven bioprocessing are further accelerating market growth, offering lucrative opportunities for stakeholders.

Market Segmentation
TypeContinuous Biomanufacturing, Batch Biomanufacturing, Hybrid Biomanufacturing
ProductBioreactors, Single-use Systems, Chromatography Systems, Filtration Systems, Centrifuges, Mixing Systems, Cell Culture Media, Buffers and Reagents
ServicesProcess Development, Consulting, Training, Maintenance and Support, Quality Assurance, Regulatory Compliance, Data Analytics
TechnologyMachine Learning, Artificial Intelligence, Internet of Things, Blockchain, Digital Twin, 3D Bioprinting, Cloud Computing, Big Data Analytics
ComponentSoftware, Hardware, Biological Components
ApplicationPharmaceuticals, Biopharmaceuticals, Gene Therapy, Cell Therapy, Vaccine Production, Enzyme Production, Biofuels
ProcessUpstream Processing, Downstream Processing, Formulation, Packaging
DeploymentOn-premise, Cloud-based, Hybrid
End UserBiotechnology Companies, Pharmaceutical Companies, Research Organizations, Academic Institutions, Contract Manufacturing Organizations
SolutionsIntegrated Solutions, Standalone Solutions, Customized Solutions

Market Snapshot:

Digital biomanufacturing is witnessing a dynamic shift in market share, influenced by competitive pricing strategies and innovative product launches. Companies are leveraging advanced biotechnologies to introduce cutting-edge solutions, enhancing their market position. The market is characterized by a diverse range of offerings, with firms focusing on both cost-effectiveness and technological superiority. This competitive landscape is further shaped by strategic partnerships and alliances, which are pivotal in driving innovation and expanding product portfolios. The competitive benchmarking in the digital biomanufacturing market reveals a landscape dominated by key industry players who are actively shaping market dynamics. Regulatory influences, particularly stringent compliance requirements in North America and Europe, are critical in setting market standards. The Asia-Pacific region is emerging as a hotspot for investment, driven by favorable regulatory frameworks and government initiatives. As the market evolves, the integration of digital technologies and automation is expected to propel growth, offering lucrative opportunities for stakeholders amidst regulatory challenges.

Geographical Overview:

The Digital Biomanufacturing Market is witnessing notable growth across various regions, each presenting unique opportunities. North America leads the market, driven by robust investments in biotechnology and advanced manufacturing technologies. The region benefits from a strong ecosystem of research institutions and biotech firms, fostering innovation and market expansion. Europe follows as a key player, with substantial investments in sustainable biomanufacturing practices. The region's focus on reducing carbon footprints and promoting green technologies enhances its market position. In the Asia Pacific, rapid technological advancements and increasing demand for biologics drive market growth. Countries like China and India are emerging as significant contributors, with government support and expanding biopharmaceutical sectors. Latin America and the Middle East & Africa are emerging markets with growing potential. In Latin America, the rising emphasis on healthcare and biotechnology investments is propelling the market. Meanwhile, the Middle East & Africa are recognizing digital biomanufacturing's role in advancing healthcare and economic development.

Key Trends and Drivers:

The Digital Biomanufacturing Market is experiencing robust growth fueled by advancements in automation and artificial intelligence. These technologies are revolutionizing the production processes, enhancing efficiency, and reducing costs. The integration of IoT devices is another trend, enabling real-time monitoring and control of bioprocesses. This connectivity facilitates data-driven decision-making, optimizing production outcomes. Moreover, the growing demand for personalized medicine is driving the market, as digital biomanufacturing allows for tailored production at scale. Regulatory bodies are increasingly supportive, recognizing the potential for innovation and efficiency in drug development. Sustainability is also a key driver, with digital solutions reducing waste and energy consumption in biomanufacturing processes. There is a rising interest in synthetic biology, which is expanding the potential applications of digital biomanufacturing. Companies are investing in R&D to harness these technologies, creating opportunities for new product development. As the industry evolves, partnerships and collaborations are emerging, fostering innovation and market expansion.

Restraints and Challenges:

The digital biomanufacturing market encounters several notable restraints and challenges. A primary challenge is the high initial investment required for cutting-edge digital technologies, which can deter smaller enterprises from entering the market. Additionally, the complexity of integrating digital systems with existing biomanufacturing processes poses significant technical hurdles, often necessitating specialized expertise. Data security and privacy concerns also present formidable obstacles, as the integration of digital systems increases the risk of cyber threats and data breaches. Regulatory compliance is another critical challenge, as navigating the intricate landscape of global regulations can be both time-consuming and costly. Furthermore, there is a scarcity of skilled professionals capable of operating and maintaining advanced digital biomanufacturing systems. This skills gap can lead to inefficiencies and hinder the effective adoption of new technologies. Collectively, these factors create substantial barriers to market growth and innovation in digital biomanufacturing.

Key Players:

Ginkgo Bioworks, Zymergen, Arzeda, Amyris, Conagen, Genomatica, Pivot Bio, Synthace, Benchling, Inscripta, Twist Bioscience, Cambrium, Evonetix, Cellibre, Molecular Assemblies

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Process
  • 2.8 Key Market Highlights by Deployment
  • 2.9 Key Market Highlights by End User
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Continuous Biomanufacturing
    • 4.1.2 Batch Biomanufacturing
    • 4.1.3 Hybrid Biomanufacturing
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Bioreactors
    • 4.2.2 Single-use Systems
    • 4.2.3 Chromatography Systems
    • 4.2.4 Filtration Systems
    • 4.2.5 Centrifuges
    • 4.2.6 Mixing Systems
    • 4.2.7 Cell Culture Media
    • 4.2.8 Buffers and Reagents
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Process Development
    • 4.3.2 Consulting
    • 4.3.3 Training
    • 4.3.4 Maintenance and Support
    • 4.3.5 Quality Assurance
    • 4.3.6 Regulatory Compliance
    • 4.3.7 Data Analytics
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Machine Learning
    • 4.4.2 Artificial Intelligence
    • 4.4.3 Internet of Things
    • 4.4.4 Blockchain
    • 4.4.5 Digital Twin
    • 4.4.6 3D Bioprinting
    • 4.4.7 Cloud Computing
    • 4.4.8 Big Data Analytics
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Software
    • 4.5.2 Hardware
    • 4.5.3 Biological Components
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Pharmaceuticals
    • 4.6.2 Biopharmaceuticals
    • 4.6.3 Gene Therapy
    • 4.6.4 Cell Therapy
    • 4.6.5 Vaccine Production
    • 4.6.6 Enzyme Production
    • 4.6.7 Biofuels
  • 4.7 Market Size & Forecast by Process (2020-2035)
    • 4.7.1 Upstream Processing
    • 4.7.2 Downstream Processing
    • 4.7.3 Formulation
    • 4.7.4 Packaging
  • 4.8 Market Size & Forecast by Deployment (2020-2035)
    • 4.8.1 On-premise
    • 4.8.2 Cloud-based
    • 4.8.3 Hybrid
  • 4.9 Market Size & Forecast by End User (2020-2035)
    • 4.9.1 Biotechnology Companies
    • 4.9.2 Pharmaceutical Companies
    • 4.9.3 Research Organizations
    • 4.9.4 Academic Institutions
    • 4.9.5 Contract Manufacturing Organizations
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Integrated Solutions
    • 4.10.2 Standalone Solutions
    • 4.10.3 Customized Solutions

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Process
      • 5.2.1.8 Deployment
      • 5.2.1.9 End User
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Process
      • 5.2.2.8 Deployment
      • 5.2.2.9 End User
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Process
      • 5.2.3.8 Deployment
      • 5.2.3.9 End User
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Process
      • 5.3.1.8 Deployment
      • 5.3.1.9 End User
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Process
      • 5.3.2.8 Deployment
      • 5.3.2.9 End User
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Process
      • 5.3.3.8 Deployment
      • 5.3.3.9 End User
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Process
      • 5.4.1.8 Deployment
      • 5.4.1.9 End User
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Process
      • 5.4.2.8 Deployment
      • 5.4.2.9 End User
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Process
      • 5.4.3.8 Deployment
      • 5.4.3.9 End User
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Process
      • 5.4.4.8 Deployment
      • 5.4.4.9 End User
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Process
      • 5.4.5.8 Deployment
      • 5.4.5.9 End User
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Process
      • 5.4.6.8 Deployment
      • 5.4.6.9 End User
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 Process
      • 5.4.7.8 Deployment
      • 5.4.7.9 End User
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Process
      • 5.5.1.8 Deployment
      • 5.5.1.9 End User
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Process
      • 5.5.2.8 Deployment
      • 5.5.2.9 End User
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Process
      • 5.5.3.8 Deployment
      • 5.5.3.9 End User
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Process
      • 5.5.4.8 Deployment
      • 5.5.4.9 End User
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Process
      • 5.5.5.8 Deployment
      • 5.5.5.9 End User
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 Process
      • 5.5.6.8 Deployment
      • 5.5.6.9 End User
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Process
      • 5.6.1.8 Deployment
      • 5.6.1.9 End User
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Process
      • 5.6.2.8 Deployment
      • 5.6.2.9 End User
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Process
      • 5.6.3.8 Deployment
      • 5.6.3.9 End User
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Process
      • 5.6.4.8 Deployment
      • 5.6.4.9 End User
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 Process
      • 5.6.5.8 Deployment
      • 5.6.5.9 End User
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Ginkgo Bioworks
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Zymergen
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Arzeda
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Amyris
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Conagen
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Genomatica
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Pivot Bio
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Synthace
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Benchling
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Inscripta
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Twist Bioscience
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Cambrium
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Evonetix
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Cellibre
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Molecular Assemblies
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us